Clinical Report: Proteomic Profiling Defines Vascular Cell States

Overview

This study presents a label-free single-cell proteomics approach to characterize vascular cell states in Marfan syndrome, emphasizing the implications for understanding disease mechanisms and potential therapeutic strategies.

Background

Understanding the cellular heterogeneity in vascular tissues is crucial for addressing diseases like Marfan syndrome, which can lead to severe cardiovascular complications. Proteomic profiling offers insights into the molecular mechanisms underlying these conditions, potentially guiding therapeutic strategies. This study highlights the importance of protein-level measurements in elucidating disease-associated cellular states.

Data Highlights

Key Findings

• A label-free proteomics workflow was used to analyze nearly 5,000 individual cells from mouse aortic tissue.
• Seven distinct phenotypes of smooth muscle cells were identified, with specific protein signatures linked to Marfan syndrome.
• Endothelial cells in Marfan mice exhibited reduced adhesion protein expression and increased smooth muscle-associated proteins.
• Integration of proteomic and transcriptomic data revealed additional cellular clusters, indicating complementary insights into cellular states.
• Potential disease markers identified include ACE, TPM4, LRP1, and PRSS2.

Clinical Implications

Discuss specific ways clinicians can integrate multi-omic approaches into patient care.

Conclusion

Highlight the broader implications for research and clinical practice in vascular diseases.

References

1. Blood Cancer Journal, 2025 -- Characterizing the Bone Marrow Plasma Proteome in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance
2. Journal of Neuro-Oncology, 2019 -- Characterization of Extracellular Vesicle Proteomes Reveals Hypoxic Conditions in U87-MG Glioma Cells, Offering Insights for Non-Invasive Diagnostic Approaches
3. Acta Neuropathologica, 2025 -- Spatial protein analysis uncovers the significant involvement of astrocytes in the core of chronic active lesions in multiple sclerosis
4. the analytical scientist — Mass Spec Roundup: Proteoforms, PFAS, and Volatilomics…
5. 2024 ESC Clinical Practice Guidelines on Peripheral Arterial and Aortic Diseases
6. 2022 ACC/AHA Aortic Disease Guideline Slide Set
7. Randomized Trial of Atenolol Versus Losartan in Children and Young Adults With Marfan Syndrome
8. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease - PMC
9. Articles Angiotensin receptor blockers and β block
10. Cardiovascular Management of Aortopathy in Children: Key Points - American College of Cardiology
11. Management of aortic disease in children with FBN1-related Marfan syndrome - PubMed
12. Single-Cell Proteomics Reveals Novel Cell Phenotypes in Marfan Mouse Aneurysm - PMC
13. Genetic testing in thoracic aortic disease: diagnostic performance of the 2024 ESC algorithm | European Heart Journal | Oxford Academic
14. Thoracic aortic diseases: Identification of diagnostic biomarkers using proteomic analysis - ScienceDirect